On Tuesday, U.S. health authorities urged states and healthcare providers pause use of Johnson & Johnson’s coronavirus vaccine, citing reports of a rare but serious side effect. According to the Food and Drug Administration and the Centers for Disease Control and Prevention, six women in the U.S. have experienced an unusual combination of blood clots… Read More »
The Food and Drug Administration on Saturday gave emergency authorization to a coronavirus vaccine developed by Johnson & Johnson, making a third shot available at a critical moment for U.S. efforts to control COVID-19. J&J’s vaccine, which requires one dose rather than two and can be stored at refrigerator temperatures, will provide much-needed reinforcements as… Read More »
Johnson & Johnson’s multiple myeloma drug Darzalex has another FDA nod in previously untreated patients under its belt—and this one is a first for a biologic. The FDA has approved Darzalex in combination with Takeda’s Velcade, thalidomide and dexamethasone (VTd) for new patients who are eligible for stem cell transplant, making it the first biologic… Read More »